summit trial tirzepatide results Tirzepatide: A Systematic Update AHA 24 Late-Breaking Discussion: SUMMIT:

Sergey Terushkin, MD, FACS The patients who have the best experience with tirzepatide are the ones who stay in close contact with their care team

Many patients report improvements in mood and self-esteem following weight loss with GLP-1 agonists

The article lists inadequate protein or calorie intake, dehydration, sleep disruption, anemia, thyroid dysfunction and other medications as things that can compound tiredness during treatment

Theres no one-size-fits-all best GLP-1 drug for everyone

Clinical trials show semaglutide produces 6070% hunger reduction and 1517% weight loss, far exceeding typical diet-only results (35% loss) or exercise-alone results (23% loss)